Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Colorcon
Moodys
Boehringer Ingelheim
Medtronic

Last Updated: December 9, 2021

DrugPatentWatch Database Preview

HETERO LABS LTD III Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for HETERO LABS LTD III, and what generic and branded alternatives to HETERO LABS LTD III drugs are available?

HETERO LABS LTD III has fifty-three approved drugs.

There are five tentative approvals on HETERO LABS LTD III drugs.

Summary for HETERO LABS LTD III
US Patents:0
Tradenames:43
Ingredients:42
NDAs:53

Drugs and US Patents for HETERO LABS LTD III

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hetero Labs Ltd Iii TADALAFIL tadalafil TABLET;ORAL 209908-003 Mar 26, 2019 AB1 RX No No ⤷  Try it Free ⤷  Try it Free
Hetero Labs Ltd Iii EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE emtricitabine; tenofovir disoproxil fumarate TABLET;ORAL 201806-001 Oct 7, 2021 AB RX No No ⤷  Try it Free ⤷  Try it Free
Hetero Labs Ltd Iii CLOBAZAM clobazam TABLET;ORAL 209795-001 Oct 22, 2018 AB RX No No ⤷  Try it Free ⤷  Try it Free
Hetero Labs Ltd Iii LEVETIRACETAM levetiracetam TABLET;ORAL 090515-001 Oct 8, 2010 AB RX No No ⤷  Try it Free ⤷  Try it Free
Hetero Labs Ltd Iii NEBIVOLOL HYDROCHLORIDE nebivolol hydrochloride TABLET;ORAL 203825-004 Nov 3, 2020 AB RX No No ⤷  Try it Free ⤷  Try it Free
Hetero Labs Ltd Iii CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride SYRUP;ORAL 210622-001 Mar 13, 2019 OTC No No ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for HETERO LABS LTD III drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Johnson and Johnson
Baxter
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.